Natl Beverage Corp (NQ: FIZZ )

48.95 -0.67 (-1.35%)
Streaming Delayed Price Updated: 10:53 AM EST, Nov 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Natl Beverage Corp

< Previous 1 2 Next >
Vita Coco Garners Tasty Profits, Trades Just Below All-Time High
Vita Coco closed at 13.95 shortly after its IPO in October 2021. Monday it closed at 27.87, about double from 2-3/4 years ago. 
Via Investor's Business Daily
Topics Initial Public Offering
Exposures Securities Market
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Top performers last week: Tempus AI +30%, Enovix Corp +29%, Grindr Inc +27.5%, Trump Media +18.33%, Credo Tech +18.3%, Tecnoglass Inc +17.9%, STAAR Surgical +16.55%, RXO Inc +16.22%, Global-E Online... 
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
FIZZ Stock Earnings: National Beverage Meets EPS, Beats Revenue for Q4 2024
FIZZ stock results show that National Beverage met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
FIZZ Stock Earnings: National Beverage Beats EPS, Misses Revenue for Q3 2024
FIZZ stock results show that National Beverage beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. 
Via InvestorPlace
FIZZ Stock Earnings: National Beverage Meets EPS, Misses Revenue for Q2 2024
FIZZ stock results show that National Beverage met analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Looking Into National Beverage's Return On Capital Employed
Via Benzinga
Recap: National Beverage Q4 Earnings
Via Benzinga
National Beverage's Return On Capital Employed Insights
Via Benzinga
7 Strong Sell Stocks Ready to Take a Deep Dive
If you own any of these seven strong sell stocks, consider now the perfect time to take the money and run. 
Via InvestorPlace
7 Consumer Stocks to Sell in September Before They Crash & Burn
With discretionary cash becoming scarce and analyst sentiment souring, it’s time to look at consumer stocks to sell. 
Via InvestorPlace
Stratasys, PLAYSTUDIOS, PlayAGS And Other Big Stocks Moving Higher On Friday
U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
2 Stocks That Turned $10,000 Into $40,000 (or More)
Shareholder patience was rewarded in these cases. 
Via The Motley Fool
2022 Was a Sparkling Year for Carbonated Beverage Stocks
Most of the major carbonated beverage stocks moved higher last year. 
Via The Motley Fool
National Beverage Registers 5.8% Revenue Growth In Q2
Via Benzinga
Why National Beverage Shares Are Falling
National Beverage Corp. (NASDAQ:FIZZ) shares are trading l... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
As the Fed continues to tighten the market, consider putting these seven on your list of overvalued Nasdaq stocks to sell before 2022 ends. 
Via InvestorPlace
Monster Beverage Stock Strengthens; Near All-Time High
The 84 RS Rating means that Monster Beverage stock outperformed 84% of stocks in terms of price performance over the past year. 
Via Investor's Business Daily
National Beverage And 2 Other Stocks Insiders Are Selling
US crude oil futures traded lower this morning on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
As Lyft Faces a Price-Fixing Lawsuit, Here Are 2 Better Stocks to Buy
Lyft closed 2019 at $43.50. In 30 months since, LYFT stock lost 66% of its value. There are better options around its current price. 
Via InvestorPlace
Why Does Elon Musk Feel 'Swindled' When He Drinks This Sparkling Water Brand?
Tesla, Inc. 
Via Benzinga
National Beverage's Return On Capital Employed Insights
Pulled from Benzinga Pro data, National Beverage (NASDAQ:FIZZ) posted Q3 earnings of $31.07 million, an increase from Q2 of 20.91%. Sales dropped to $258.92 million, a 8.56%... 
Via Benzinga
National Beverage Launches LaCroix Cherry Blossom Flavor
National Beverage Corp (NASDAQ: FIZZ) has unveiled a new Cherry Blossom flavor. LaCroix Cherry Blossom will be available at select retailers nationwide in March 2022.... 
Via Benzinga
10 High-Performance Stocks to Buy for Their Special Dividends
Some of the best dividend stocks happen to be those paying special dividends from time to time. These payments often signal future success. 
Via InvestorPlace
Looking Into National Beverage's Return On Capital Employed
According to Benzinga Pro, during Q2, National Beverage (NASDAQ:FIZZ) earned $39.28 million, a 27.0% increase from the preceding quarter. National Beverage's sales decreased... 
Via Benzinga
Positioning In SmileDirectClub Highest On Record
Let's take a look at this week's short interest trends among some of the most widely followed high-short-float stocks. 
Via Talk Markets
National Beverage Drinks Up Big Gains Despite Supply Chain Headwinds
The carbonated beverage maker delivered a standout quarter, contrary to analyst pessimism. 
Via The Motley Fool
National Beverage Shares Rally After Q1 Earnings Beat Estimates
National Beverage Corp (NYSE: FIZZ) reported first-quarter FY22 sales growth of 6.2% year-on-year, to $311.7 million, beating the consensus of $299.19 million. The... 
Via Benzinga
Topics Earnings
Exposures Financial
60 Biggest Movers From Friday
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.